Beryllium Discovery has become a fully owned subsidiary of UK-based pharmaceutical company UCB Pharma, with the latter acquiring the remaining stake in the former.

"China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province."

The target company is a drug discovery contract research organisation.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acquirer company expects the acquisition to help grow its pipeline.

China Meheco has announced its plans to acquire 54% stake in a pharmaceutical company based in the Hainan province.

The purchase consideration for the transaction is expected to be CNY286.2m ($42.05m).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Recognised with 2025 Excellence Awards for Research and Development and Marketing , Novotech converted FDA/EMA fast track designations into faster HDV trial timelines while translating complex HBV science into sponsor ready insights. Discover how this dual strength in execution and communication is reshaping liver disease clinical development.

Discover the Impact